Blenrepの併用療法が6つ目の規制当局の承認を獲得、主要市場すべてで申請が審査中
gsk.com
Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractory multiple myeloma
RSS Hunter
2025-07-24
Create attached notes ...